Labelling legalized marijuana products with their levels of two main active ingredients is one of the helpful recommendations released this week by a federal task force on cannabis legalization and regulation, says Saskatoon addictions expert Dr. Peter Butt.
“There’s no truth in labelling now because there’s no testing,” Butt said.
He is concerned that there is no way to ensure cannabis sold for medicinal use contains any of a substance shown to produce the medical benefits marijuana is promoted to address. Instead, the plant has been mainly produced to maximize its content of the substance that produces intoxication.
Butt said he believes most of the “medical marijuana” that’s sold is actually purchased for recreational use.
“This unregulated marketing is such a free-for-all, it’s a bit of a mess … It’s going to be a much more regulated environment, which is good.”
Butt said he is pleased the task force recommends legislation be written from a public health approach, seeking to minimize harm and use the revenue for education and research that will increase knowledge.